Blog

Sep 23, 2016

MIT-Led Team Creates Freeze-Dried Cellular Components to Produce Biopharmaceuticals on Demand

Posted by in category: biotech/medical

A team of researchers at MIT and other institutions have developed miniature freeze-dried pellets that possess all of the molecular machinery required to convert DNA into proteins, which could form the basis for on-demand production of vaccines and drugs.

The pellets, which hold several enzymes and other molecules extracted from cells, can be stored for prolonged period of time at room temperature. When water and freeze-dried DNA are added, the pellets start to produce proteins encoded by the DNA.

It’s a modular system that can be programmed to make what you need, on the spot. You could have hundreds of different DNA pellets you can add in the field.

Read more

Comments are closed.